companydata.dkcompanydata.dk

Reumatolog Khurram Ashraf ApS: Financial statements 2018

CVR: 39336081

Source: annual report 2018, Danish Business Authority

01/02/2018 – 31/12/2018

Reumatolog Khurram Ashraf ApS (CVR 39336081) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 48,108 and a net result of DKK 36,913. Equity in the 2018 report amounted to DKK 36,914. The solvency ratio was 73.2%.

Gross Profit
DKK 48,108
Profit/Loss
DKK 36,913
Equity
DKK 36,914
Total Assets
DKK 50,409

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2018

Khurram Ashraf joins Reumatolog Khurram Ashraf ApS as adm. dir.Feb 1, 2018

As of February 1, 2018, Khurram Ashraf is registered as adm. dir. of Reumatolog Khurram Ashraf ApS.

Speciallægen FZJ Holding ApS registered as owner of Reumatolog Khurram Ashraf ApSFeb 1, 2018

As of February 1, 2018, Speciallægen FZJ Holding ApS is registered as an owner of Reumatolog Khurram Ashraf ApS with an ownership share of 100%.

Reumatolog Khurram Ashraf ApS is foundedFeb 1, 2018

Reumatolog Khurram Ashraf ApS was founded on February 1, 2018.

About Reumatolog Khurram Ashraf ApS

Reumatolog Khurram Ashraf ApS is a Danish company of the type Anpartsselskab based in Hillerød, founded in 2018. The company is registered under the industry Alment praktiserende lægers aktiviteter. The company was previously named Reumatolog Khurram Ashraf IVS. The management consists of Khurram Ashraf. The company is owned by Speciallægen FZJ Holding ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 633,663 and a net result of DKK 130,666 compared with DKK 46,332 the year before. Equity in the 2025 report amounted to DKK 52,832.

Source: annual report 2025, Danish Business Authority

Other financial years